Data source: the following information from the enterprise credit agency, more detailed enterprise risk data, the company's official website, the company profile, can be in the nail enterprise dictionary on the query, more company recruitment information consult the company's official website.
Company Profile:
Renfu Pharmaceutical Group Co., Ltd. was founded in 1993-03-30, with a registered capital of RMB 135370.430200 million, the legal representative is Wang Xuehai, the company's address is No. 666 Gaoxin Avenue in Wuhan East Lake Hi-Tech Zone, and the unified social credit code and tax ID number is 914201003000148505, the industry is scientific research, technical services and geological survey industry, the registration authority is Wuhan East Lake New Technology Development Zone Market Supervision Administration, the business scope of pharmaceutical research and development; biotechnology research and development; chemical products (except chemical hazards) research and development, sales; technology development, technology transfer and technical services; import and export of goods, import and export of technology, agents, import and export (excluding the prohibition or restriction of import and export). Import and export (excluding goods or technologies prohibited or restricted by the state); investment in the pharmaceutical industry and medical institutions; management of the pharmaceutical industry and medical institutions; real estate development and sales of commercial properties (qualification level 3); organization of the "three to one subsidy" business. (Items subject to approval by law can only be carried out after approval by the relevant departments), Renfo Pharmaceutical Group Co. Ltd., the legal representative is Li Qianlun, the date of capital contribution is 2009-04-08, the enterprise status is in business (open), the registered capital is 2000.000000, the proportion of capital contribution is 51.00%
Zhiyin Xincheng (Wuhan) Equity Investment Management Co. 1000.000000, the proportion of capital contribution is 49.00%
Xinjiang Uygur Pharmaceutical Co., Ltd, the legal representative is Yin Qiang, capital contribution date is 2001-03-26, enterprise status is in business (open), registered capital is 2000.000000, the proportion of capital contribution is 73.25%
Yichang Maternity and Children's Hospital Management Co. The legal representative is Liu Lei, capital contribution date is 2016-05-19, enterprise status is in business (open), registered capital is 52967.530000, the proportion of capital contribution is 66.00%
Sichuan Renfu Pharmaceuticals Ltd, the legal representative is Tian Ping, capital contribution date is 2005-09-20, enterprise status is in business (open), registered capital is 10900.000000, the proportion of capital is 70.00%
Wuhan Renfu Medical Optical Electronics Co., Ltd, the legal representative is Xu Jiansheng, capital contribution date is 1998-07-30, enterprise status is in business (open), registered capital is 500.000000, the proportion of 70.00%
Wuhan Kefu New Drugs Co. Ltd., the legal representative is Shen Jie, capital contribution date is 2007-08-03, enterprise status is in business (open), registered capital is 1000.000000, the proportion of capital is 65.00%
Hubei Renfu Chengtian Pharmaceutical Co. 8093.000000, the proportion of capital is 51.81%
Hubei Mulan Tongda Science and Technology Co., Ltd, the legal representative is Xia Mulan, capital contribution date is 2003-06-20, enterprise status is in business (open), registered capital is 2000.000000, the proportion of capital is 19.00%
Hangzhou Foster Pharmaceuticals Co. The legal representative is Xu Zhuqing, capital date is 2001-09-05, enterprise status is in operation (business), the registered capital is 750.000000, the proportion of capital is 70.00%
Yichang Three Gorges Pharmaceutical Co. 39000.000000, the proportion of capital is 100.00%
Wuhan Ruicheng Equity Investment Management Company Limited, the legal representative is Sun Jing, the date of capital is 2015-05-28, enterprise status is in business (open), the registered capital is 500.000000, the proportion of capital is 32.50%
Wuhan Bowo Bio-technology Co. Ltd., the legal representative is Wu Ke, capital date is 2012-12-31, enterprise status is in business (open), the registered capital is 7764.977800, the proportion of capital is 6.26%
Beijing Barry Medical Devices Co. 1000.000000, the proportion of capital is 80.00%
Guangzhou Beilong Environmental Protection Thermal Equipment Co. Investment Fund Center (Limited Partnership), the legal representative is Wuhan Ruicheng Equity Investment Management Co Ltd (Appointed Representative: Li Qianlun), the date of capital contribution is 2016-11-17, the enterprise status is in operation (open), the registered capital is 25000.000000, the proportion of capital contribution is 19.00%
Hubei Shanzhuo Housing Leasing Co Ltd, the legal representative is Xia Yuan, the Ltd., the legal representative is Sun Tingjuan, the capital date is 2007-10-25, the enterprise status is canceled, the registered capital is 300.000000, the proportion of capital is 100.00%
Hubei Radio and Television Sunshine Charity Culture Media Co. Ltd., the legal representative is Huang Yan, capital date is 2010-03-12, enterprise status is in business (open), registered capital is 6000.000000, capital ratio is 27.50%
Tianfeng Securities Company Limited, the legal representative is Yu Lei, capital date is 2000-03-29, capital is 27.50%
Tianfeng Securities Co. 2000-03-29, enterprise status is in business (open), registered capital is 518000.000000, the proportion of 2.88%
Shareholders:
Social circulation of the shares, the proportion of 23.48% of the capital contribution, the contribution is 31786.016500
Wuhan Contemporary Science and Technology Industry Group Co. Ltd., contributed 6.12% of the capital, contributed 8284.051000
Huabao Trust Co., Ltd., contributed 1.48% of the capital, contributed 2000.000000
Taikang Asset Management Co., Ltd., contributed 0.96% of the capital, contributed 1300.000000
China Chengxin Trust Co. p>
Chengxin Trust Co., Ltd., with an investment ratio of 0.96%, contributed 1300.000000
Rongtong Fund Management Co., Ltd., with an investment ratio of 0.74%, contributed 1000.000000
Dongfang Securities Co. 750.000000
Wuhan Gaoke State-owned Holding Group Co., Ltd, the proportion of 0.55%, contributed 738.501100
Executives:
Li Jie serves as a director and general manager of the company
Deng Xiafei serves as a director of the company
Du Yuexin serves as a supervisor of the company
Du Yuexin serves as a supervisor of the company. Supervisor in the Company
Zhou Hansheng serves as Director in the Company
Zhu Jianmin serves as Supervisor in the Company
He Qisheng serves as Director in the Company
Zhang Xiaodong serves as Director in the Company
Gai Songmei serves as Supervisor in the Company
Wang Xuegong serves as Director in the Company
Qimin serves as Supervisor in the Company
Wang Xuehai serves as Chairman and General Manager of the Company. >Wang Xuehai serves as Chairman of the Board of Directors of the Company
Xie Yubao serves as Director of the Company
Huang Feng serves as Director of the Company
He Hao serves as Supervisor of the Company
.